β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing

American Heart Journal

Volumn 160, Issue 3, 2010, Pages

  Goldberger, Jeffrey J ^a   Bonow, Robert O ^a   Cuffe, Michael ^b   Dyer, Alan ^a   Rosenberg, Yves ^c   O'Rourke, Robert ^d   Shah, Prediman K ^e   Smith Jr , Sidney C ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PROPRANOLOL;

ADULT; AGE; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE REGISTRY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL PRACTICE; DRUG UTILIZATION; MIDDLE AGED; MYOCARDIAL INFARCTION; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY ASSURANCE, HEALTH CARE;

EID: 77956378871     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.023     Document Type: Article

References (40)

1. ß-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results JAMA 247 1982 1707 1714
2. CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
3. Hjalmarson A., Herlitz J., and Malek I. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial Lancet 2 1981 823 827
4. Pedersen T. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction N Engl J Med 313 1985 1055 1058
5. Teo K., Yusuf S., and Furberg C. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials JAMA 270 1993 1589 1595
6. Gottlieb S., McCarter R., and Vogel R. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
7. Krumholz H., Radford M., and Wang Y. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project JAMA 280 1998 623 629
8. Soumerai S., McLaughlin T., and Spiegelman D. Adverse outcomes of underuse of b-blockers in elderly survivors of acute myocardial infarction JAMA 277 1997 115 121
9. Gunnar R., Bourdillon P., and Dixon D. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients With Acute Myocardial Infarction) Circulation 82 1990 664 707
10. Avanzini F., Zuanetti G., and Latini R. Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? Eur Heart J 18 1997 1447 1456
11. Barron H., Viskin S., and Lundstrom R. Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization Arch Intern Med 158 1998 449 453
12. Brand D., Newcomer L., and Freiburger A. Cardiologists' practices compared with practice guidelines: use of beta-blockage after acute myocardial infarction J Am Coll Cardiol 26 1995 1432 1436
13. Cheema A., Sheu K., and Parker M. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction Circulation 98 1998 2030 2036
14. Chen J., Radford M., and Wang Y. Do 'America's best hospitals' perform better for acute myocardial infarction N Engl J Med 340 1999 286 292
15. Danchin N., Vaur L., and Genes N. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the 'real world': one-year results from a nationwide French survey Circulation 99 1999 2639 2644
16. Haim M., Behar S., and Boyko V. The prognosis of a first Q-wave versus non-Q-wave myocardial infarction in the reperfusion era Am J Med 108 2000 381 386
17. McGovern P., Pankow J., and Shahar E. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors N Engl J Med 334 1996 884 890
18. Viskin S., Kitzis I., and Lev E. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice J Am Coll Cardiol 25 1995 1327 1332
19. Krumholz H., Anderson J., and Bachelder B. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine J Am Coll Cardiol 52 2008 2046 2099
20. Krumholz H., Anderson J., and Brooks N. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction) Circulation 113 2006 732 761
21. Peterson E., Roe M., and Mulgund J. Association between hospital process performance and outcomes among patients with acute coronary syndromes JAMA 295 2006 1912 1920
22. Lee H., Cooke C., and Robertson T. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge J Manag Care Pharm 14 2008 271 280
23. Kotseva K., Wood D., and De Backer G. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137
24. Gislason G., Rasmussen J., and Abildstrom S. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur Heart J 27 2006 1153 1158
25. Rochon P., and Gurwitz J. Prescribing for seniors: neither too much nor too little JAMA 282 1999 113 115
26. Chen Z.M., Pan H., and Chen Y. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
27. Goldberger J., Bonow R., and Cuffe M. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial Am Heart J 155 2008 455 464
28. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
29. Pfisterer M., Cox J., and Granger C. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience J Am Coll Cardiol 32 1998 634 640
30. The Norwegian Multicenter Study Group Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
31. Wikstrand J., Hjalmarson A., and Waagstein F. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF) J Am Coll Cardiol 40 2002 491 498
32. Dobre D., van Veldhuisen D., and Mordenti G. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial Am Heart J 154 2007 109 115
33. Antman E., Anbe D., and Armstrong P. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 588 636
34. Ryan T., Antman E., and Brooks N. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 100 1999 1016 1030
35. Bristow M., Gilbert E., and Abraham W. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 1996 2807 2816
36. Metra M., Torp-Pedersen C., and Swedberg K. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial Eur Heart J 26 2005 2259 2268
37. Devereaux P., and Yang H. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 2008 1839 1847
38. Jack B., Chetty V., and Anthony D. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial Ann Intern Med 150 2009 178 187
39. Ho P., Spertus J., and Masoudi F. Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 2006 1842 1847
40. Hansteen V., Moinichen E., and Lorentsen E. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial Br Med J Clin Res Ed 284 1982 155 160